News Clinical Pharmacist’s monthly news round-up: the top 10 in October 2014What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month……Published: 24 October 2014
News BNF revises domperidone advice and introduces new monoclonal antibody Children and their carers who use domperidone for gastro-oesophageal reflux disease should be told how to recognise symptoms of arrhythmia, according to the latest update from the British National Formulary.…Published: 24 October 2014
News Research confirms faecal microbiota transplantation is safe and effective An age-old treatment has shown remarkable clinical cure rates for Clostridium difficile infection, achieving far better outcomes than antimicrobial therapy.…Published: 24 October 2014
News Effective treatments lagging behind for multidrug-resistant TB, says WHO There are still major gaps in delivering effective treatments to patients suffering from multidrug-resistant tuberculosis, a report finds.…Published: 24 October 2014
News Johnson & Johnson accelerates Ebola vaccine push Johnson & Johnson’s pharmaceuticals unit, Janssen, will invest US$200m in accelerating and expanding production of its Ebola vaccine.…Published: 24 October 2014
Opinion Vaccine evaluation process needs urgent reform The Joint Committee on Vaccination and Immunisation needs to be more open about how it decides which vaccines should be recommended for use in the UK.…Published: 23 October 2014
Opinion Not every problem is viral We must not allow fears about Ebola and other viruses to obscure the threat of antimicrobial resistance, writes Eamonn McArdle.…Published: 23 October 2014
News Treatment tested for patients with visceral leishmaniasis and HIV in Africa The efficacy and safety of amphotericin plus miltefosine to treat visceral leishmaniasis patients with HIV will be examined in a Phase III randomized clinical trial in Ethiopia.…Published: 21 October 2014
Feature Investigating treatment strategies for the Middle East respiratory syndrome coronavirus Researchers are investigating a number of ways to combat the outbreak of Middle East respiratory syndrome coronavirus, including using existing drugs.…Published: 20 October 2014
News Options explored for HIV patients unable to take efavirenz A clinical trial has evaluated alternatives to first-line therapy efavirenz in treatment-naïve HIV-infected patients. …Published: 17 October 2014